PAVmed Inc. Cash And Cash Equivalents At Carrying Value

Quick Answer

PAVmed Inc. reported Cash And Cash Equivalents At Carrying Value of $1.54 million for the year ending 2025.

  • PAVmed Inc. showed an increase of +29.8% in Cash And Cash Equivalents At Carrying Value from 2024 to 2025.
  • This data is from PAVmed Inc.'s annual report (Form 10-K), filed with the SEC on March 27, 2026.
  • XBRL data for this metric is available from 2014 to 2025 (12 years of filings). Earlier data may not exist in machine-readable XBRL format as companies adopted electronic filing at different times.
  • Over the full 12 years of available data (2014 to 2025), PAVmed Inc.'s Cash And Cash Equivalents At Carrying Value has grown by 83.3%.
  • Historical annual values: Fiscal year 2025: $1.54 million | Fiscal year 2024: $1.19 million | Fiscal year 2023: $19.64 million | Fiscal year 2022: $39.74 million | Fiscal year 2021: $77.26 million | Fiscal year 2020: $17.26 million | Fiscal year 2019: $6.22 million | Fiscal year 2018: $8.22 million | Fiscal year 2017: $1.54 million | Fiscal year 2016: $585.7 thousand | Fiscal year 2015: $767.3 thousand | Fiscal year 2014: $839.1 thousand.
  • Data sourced from SEC EDGAR public filings as of June 23, 2026.

Last verified: